Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are covering the stock, Ratings reports. Seven research analysts have ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

KEY and BNS complete the final tranche of equity investment in the former. This transaction will likely drive KeyCorp's NII ...

The Bank of Nova Scotia (Scotiabank) has completed its purchase of KeyCorp’s common stock with an investment of approximately ...

The Bank of Nova Scotia (Scotiabank) has finalized its $2 billion investment in KeyCorp, acquiring approximately 14.9% of the ...

Shares of KeyCorp (NYSE:KEY – Get Free Report) have received a consensus rating of “Moderate Buy” from the eighteen ...

In a collaboration with Coinbase and Flexa, Regal theaters now accept on-chain U.S. digital currency payments for movie tickets and concessions; the Bank of Nova Scotia has completed its second ...

The stock's fall snapped a four-day winning streak.

TORONTO — Bank of Nova Scotia says it has closed its two-part deal to buy a 14.9 per cent stake in U.S. bank KeyCorp for ...

Scotiabank, which now owns 14.9% of the U.S. bank, says the deal is a cost-effective, low-risk way to invest in America ...

Bank Of Nova Scotia (TSE:BNS) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

KeyCorp (KEY) announced that The Bank of Nova Scotia (BNS) has completed its purchase of KeyCorp’s common stock with an investment of ...